Literature DB >> 8057446

Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors.

G Podsakoff1, K K Wong, S Chatterjee.   

Abstract

Gene transfer vectors based on adeno-associated virus (AAV) are emerging as highly promising for use in human gene therapy by virtue of their characteristics of wide host range, high transduction efficiencies, and lack of cytopathogenicity. To better define the biology of AAV-mediated gene transfer, we tested the ability of an AAV vector to efficiently introduce transgenes into nonproliferating cell populations. Cells were induced into a nonproliferative state by treatment with the DNA synthesis inhibitors fluorodeoxyuridine and aphidicolin or by contact inhibition induced by confluence and serum starvation. Cells in logarithmic growth or DNA synthesis arrest were transduced with vCWR:beta gal, an AAV-based vector encoding beta-galactosidase under Rous sarcoma virus long terminal repeat promoter control. Under each condition tested, vCWR:beta Gal expression in nondividing cells was at least equivalent to that in actively proliferating cells, suggesting that mechanisms for virus attachment, nuclear transport, virion uncoating, and perhaps some limited second-strand synthesis of AAV vectors were present in nondividing cells. Southern hybridization analysis of vector sequences from cells transduced while in DNA synthetic arrest and expanded after release of the block confirmed ultimate integration of the vector genome into cellular chromosomal DNA. These findings may provide the basis for the use of AAV-based vectors for gene transfer into quiescent cell populations such as totipotent hematopoietic stem cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057446      PMCID: PMC236967     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector.

Authors:  D LaFace; P Hermonat; E Wakeland; A Peck
Journal:  Virology       Date:  1988-02       Impact factor: 3.616

Review 2.  Adeno-associated viruses: an update.

Authors:  K I Berns; R A Bohenzky
Journal:  Adv Virus Res       Date:  1987       Impact factor: 9.937

3.  Cell cycle dependence of synthesis of unintegrated viral DNA in mouse cells newly infected with murine leukemia virus.

Authors:  J Harel; E Rassart; P Jolicoeur
Journal:  Virology       Date:  1981-04-15       Impact factor: 3.616

4.  Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells.

Authors:  J D Tratschin; I L Miller; M G Smith; B J Carter
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

5.  Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types.

Authors:  J S Lebkowski; M M McNally; T B Okarma; L B Lerch
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

6.  Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells.

Authors:  G Li; M Simm; M J Potash; D J Volsky
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells.

Authors:  P L Hermonat; N Muzyczka
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

8.  Expression of the human beta-globin gene after retroviral transfer into murine erythroleukemia cells and human BFU-E cells.

Authors:  M A Bender; A D Miller; R E Gelinas
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

9.  Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication.

Authors:  R M Buller; J E Janik; E D Sebring; J A Rose
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

10.  Adeno-associated virus general transduction vectors: analysis of proviral structures.

Authors:  S K McLaughlin; P Collis; P L Hermonat; N Muzyczka
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

View more
  53 in total

1.  Enhanced long-term transduction and multilineage engraftment of human hematopoietic stem cells transduced with tyrosine-modified recombinant adeno-associated virus serotype 2.

Authors:  M Ariel Kauss; Laura J Smith; Li Zhong; Arun Srivastava; K K Wong; Saswati Chatterjee
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

2.  Use of Adeno-Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice.

Authors:  Rachel D Penrod; Audrey M Wells; William A Carlezon; Christopher W Cowan
Journal:  Curr Protoc Neurosci       Date:  2015-10-01

Review 3.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

4.  Stem cell technology. Interview by Abi Berger.

Authors:  P A Fontes; A W Thomson
Journal:  BMJ       Date:  1999-11-13

5.  Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.

Authors:  X S Wang; B Khuntirat; K Qing; S Ponnazhagan; D M Kube; S Zhou; V J Dwarki; A Srivastava
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products.

Authors:  K A Vincent; S T Piraino; S C Wadsworth
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 7.  Large animal models of neurological disorders for gene therapy.

Authors:  Christine Gagliardi; Bruce A Bunnell
Journal:  ILAR J       Date:  2009

Review 8.  Current status of gene therapy for rheumatoid arthritis.

Authors:  Daniel F Gaddy; Paul D Robbins
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

9.  Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex.

Authors:  Jason O'Donnell; Kenneth A Taylor; Michael S Chapman
Journal:  Virology       Date:  2009-01-13       Impact factor: 3.616

10.  Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.

Authors:  Guy L Odom; Paul Gregorevic; James M Allen; Eric Finn; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.